Leadership Speaker Series: Adeno Associated Virus (AAV) As A Gene Therapy Vector And Its Bioproduction | SGInnovate

SGInnovate Website Maintenance Notice

SGInnovate.com & STARS.SGInnovate.com will be temporarily unavailable from 05 Dec 2022, 22:00 to 06 Dec 2022, 08:00 (SGT).

We apologise for any inconvenience and thank you for your patience during this time.

October 12 2022

Location

Online Event
Singapore

ENDED

Leadership Speaker Series: Adeno Associated Virus (AAV) As A Gene Therapy Vector And Its Bioproduction

Presented by SGInnovate and Stack Family Center for Biopharmaceutical Education and Training (CBET)

Adeno Associated Virus (AAV) is the gene therapy vector of choice – delivering it’s DNA payload to have a therapeutic effect primarily via gene replacement

Join us to learn about successes with AAV as a gene therapy vector, current headwinds to approval of new therapies and challenges associated with the manufacturing of AAV. In particular how the industry may address increasing yield and separation of vectors that do not contain DNA payload, so called “empty” vectors that do not provide therapeutic benefit.

Date: 12 October 2022
Time: 4:00am - 5:00am (Singapore Time / UTC +8) or 4:00pm - 5:00pm (EST)

Event Programme: 
4:00am - 5:00am: 
Leadership Speaker Series: Adeno Associated Virus (AAV) as a Gene Therapy Vector and its Bioproduction with:

  • Mark Schofield, Senior R&D Manager, Pall Biotech
Speaker's Profile: 
Mark Schofield, Senior R&D Manager, Pall Biotech

image
Mark Schofield earned his degrees in Scotland he received his bachelor’s degree from the University of Edinburgh and his molecular biology PhD from the University of Dundee. For the last 10 years, he has been an employee of Pall Life Sciences, focusing on chromatography applications. Currently, he holds the position of Senior R&D manager, his team works on chromatography solutions for continuous bioprocessing and gene therapy modalities.






 

Topics: MedTech / HealthTech / BioTech, Talent and Mentoring

Industry: Health and BioMedical Sciences